Vimarsana
Biggest News Aggregation in the World

Page 3 - Standard Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Standard Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Standard Diagnostics Today - Breaking & Trending Today

Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant - Vimarsana News

Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa - Vimarsana News

Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa

Isolde Birdthistle and co-workers evaluate a program to address risks of HIV infection in adolescent girls and young women in sub-Saharan Africa.

Source: plos.org
Korean Covid-19 Test Maker Prepares For IPO Amid Revenue Leap, Founder To Become Billionaire - Vimarsana News

Korean Covid-19 Test Maker Prepares For IPO Amid Revenue Leap, Founder To Become Billionaire

Korean Covid-19 Test Maker Prepares For IPO Amid Revenue Leap, Founder To Become Billionaire Share to Facebook COURTESY OF SD Biosensor Cho Young-sik, founder of Covid-19 test maker SD Biosensor, is set to become a billionaire this month, when the South Korean company is expected to list its shares on the Korea Exchange. SD Biosensor is offering 12.4 million shares at a price range of 45,000 won to 52,000 won apiece. At the midpoint of that range, the deal could raise 603 billion won (about $530 million) and value the company at 4.9 trillion won. The subscription period is to start July 8 and...

Source: forbes.com
Lyme disease: Gold Standard Diagnostics announces FDA clearance of new test - Vimarsana News

Lyme disease: Gold Standard Diagnostics announces FDA clearance of new test

Gold Standard Diagnostics (GSD) recently announced FDA clearance of a new B. burgdorferi IgG/IgM VlsE-OspC EIA test. This test, when used in conjunction with the other FDA cleared GSD Lyme EIA tests can be used in the CDC recommended modified two-tiered testing (MTTT) algorithm. Borrelia burgdorferi spirochetes/CDC In 2014, the CDC issued an updated recommendation for the serologic diagnosis of Lyme disease, endorsing the use of a two-tier testing algorithm that uses a second enzyme immunoassay, or EIA, in place of a western immunoblot assay. Gold Standard Diagnostics now offers a solution fo...

Early Release - Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions in Strains from Nigeria, Sudan, and South Sudan - Volume 27, Number 2—February 2021 - Emerging Infectious Diseases journal - Vimarsana News

Early Release - Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions in Strains from Nigeria, Sudan, and South Sudan - Volume 27, Number 2—February 2021 - Emerging Infectious Diseases journal

Plasmodium falciparum populations from Sudan, South Sudan, Nigeria, and Eritrea (A), and pfhrp2 and ... We amplified and scored 7 microsatellite loci for each sample from Sudan, South Sudan, and Nigeria (n = 86), finding 88 unique haplotypes. Two samples shared a haplotype, and we observed 2 instances of multiple haplotype infection. All 7 microsatellite markers were found to be polymorphic. We found a mean of 11 alleles per locus, a range from 6 (microsatellite markers TA109 and 2490) to 16 (microsatellite marker 383) distinct alleles. We found the genetic relatedness of P. falciparum popu...

Source: cdc.gov